跳至主要内容
临床试验/NCT04772807
NCT04772807已完成不适用

Validation of Kinocardiography, a New Technology Measuring Cardiac Mechanical Activity Via Accelerometers and Gyroscopes

Erasme University Hospital1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2021年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
1
主要终点
Feasibility of KCG measurement performed by the patients themselves

研究概览

简要总结

Kinocardiographic measures mechanical and electrical function of the heart. The proposed solution is based on measurements of body vibrations. By measuring these movements on the surface of the body, it is possible to deduce, taking into account the individual's weight and size, the quality of the heartbeat that caused this vibration. The technique developed consists of a device measuring these vibrations at two places in the body: on the torso (Seismocardiography) and on the lower back (Ballistocardiography). The first measurement is a reflection of the local strength of the heartbeat as well as the transmission of blood to the body's main artery, the aorta. The second measurement, in the lower back, is the result of the contraction and movement of blood within the arterial system. Based on these two measurements, the energy produced by the heart and transmitted to the torso or the whole body is calculated. The energy over an entire cardiac cycle and the distribution of that energy within a heartbeat are used to characterize the mechanical function of the heart.

Clinical studies carried out previously have demonstrated the repeatability of kinocardiographic measurements (KCG) and their robustness with respect to the use of different sensors.

KCG measurements also showed a high sensitivity (> 94%) to different hemodynamic states induced by the injection of active inotropic agents, i.e. dobutamine also used as a treatment for heart failure in an advanced stage. In a randomized, double-blind, cross-over study controlled by Placebo, these measurements showed a strong correlation (r = 0.8, p <0.0001) with cardiac output measured by echocardiography. The technique has also demonstrated its ability to track changes in cardiac mechanical function during expiratory voluntary apnea.

KCG measurements were also evaluated during a micro-gravity simulation in Bedrest on 23 healthy volunteers. The measurements tracked cardiac deconditioning in the control group compared to the exercise group similarly to cardiac MRI measurements. Subsequently, KCG metrics showed an ability to distinguish reduced ejection fraction (HFrEF) heart failure patients from non-insufficient patients. These latest results also showed that the chest sensor alone was sufficient to separate HFrEF patients from normative patients, laying the foundation for possible use of the smartphone alone.

The prototype of a mobile application, named OKCARDIO, makes it possible to take measurements perfectly similar to the Kino thoracic sensor, but to date have never been used it in a clinical study. Such a tool would allow anyone with a smartphone-type mobile phone to measure their cardiac mechanical function themselves and make it available to the attending physician.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged above 18 years old.
  • BMI (Body Mass Index) is below 50 kg/m
  • Fit in one of the groups

排除标准

  • Patients younger than 18 years old.
  • BMI (Body Mass Index) higher than 50 kg/m2.

结局指标

主要结局

Feasibility of KCG measurement performed by the patients themselves

时间窗: 12 weeks

Feasibility is assessed by a repeatability score, namely the intraclass correlation coefficients ranging from 0, a non repeatable measure to 1 a perfectly repeatable measure .The score is computed between measure done at the hospital by a professional and the one done by the patient at the hospital and at home.

Validation of KCG parameters by comparisons from different modalities: Kinocardiograph device and OKCARDIO smartphone application.

时间窗: Through study completion, an average of 1 year

Repeatability of OKCARDIO smartphone application recorded by an experimented operator and by the patient

时间窗: Through study completion, an average of 1 year

次要结局

  • Compliance percentage of patients measuring KCG at home with the OKCARDIO smartphone application or the Kinocardiograph device.(12 weeks)
  • Adverse events related to the use of the Kinocardiograph devices and/or OKCARDIO smartphone. Count of adverse events.(Through study completion, an average of 1 year)
  • Build a predictive score on a selection of several kinocardiography parameters based on machine learning algorithms with the aim to sort patients according to their pathological status.(12 weeks)
  • Mean and interquartile ranges of KCG derived HRV over the observation period.(Through study completion, an average of 1 year)
  • Mean and interquartile ranges of KCG derived HR over the observation period.(Through study completion, an average of 1 year)
  • Mean and interquartile ranges of KCG parameters (Kinetic Energy, namely iK) over the observation period.(Through study completion, an average of 1 year)

研究者

发起方
Erasme University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Validation of Kinocardiography, a New Technology... | 临床试验